Skip to Content

New technology gives important knowledge of myeloproliferative neoplasms

At this year’s ASH Meeting, Shira Rosenberg shared the results of genotyping of transcriptomes of CALR-mutated essential thrombocythemia patients. The study revealed that interferon-alpha promotes early lymphoid development and, uniquely in CALR mutated cells myeloid differentiation, providing a novel mechanism of actions underlying the effects of interferon-alpha in patients with myeloproliferative neoplasms.

Shira Rosenberg

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top